Drugs / Litoxetine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03397771 | Apr 2018 → May 2019 | — | Ixaltis SA | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Litoxetine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03397771 ↗ |
| Known as | Litoxetina | ChEMBL registry synonym — accepted as the source's own label CHEMBL471036 ↗ |
| Modality | Small molecule | — CHEMBL471036 ↗ |
| Route | Oral | “oral Litoxetine” NCT03397771 ↗ |